Declines in growth stocks amid inflation and rising interest rates provide a buying opportunity. Growth stocks are those that are expected by the market to increase their revenues and earnings faster on average than others in the same industry. These high-flying stocks tend to hail from the technology and communications sectors, and often exhibit elevated valuations in the form of high…
“Once a tried-and-true [COVID-19] vaccine is developed and subsequently incorporated as standard fare in medical practice, one driver of biotech will be mergers and acquisitions,” advises the author of today’s article. He proceeds to highlight an ETF that could benefit from this particular driving force – a fund that has generated a 30% return this year. For more, CLICK HERE.
When it comes to the S&P 500 and one of the ETFs that represents the overall biotech sector (the iShares Nasdaq Biotechnology ETF), the author of today’s article observes that “the paths of these two investments appear to be diverging.” Given this apparent divergence, he questions whether, despite all the recent medical news, biotech stocks have already had their run.…
Biotech stocks have been experiencing a healthy bounce, with the largest ETF that tracks the group recently hitting an all-time high following the announcement from Moderna that it was seeing early positive results with its coronavirus vaccine candidate. Some traders are cautioning investors to “tread carefully” when it comes to buying in to biotech stocks at their current levels, however,…
If you want to earn just “average” gains in the post-coronavirus economy, invest in broad index funds. But if you want better-than-average returns, stock and non-broad-based ETF picking will be the way to go, argues the author of today’s article. Just what are the many major shifts – from privacy rights to education to biotechnology – that the economy will…
Stocks? Bonds? Exchange-traded funds? Mutual funds? Annuities? Unit investment trusts? Real estate? Given the wide range of options available when choosing investments for an Individual Retirement Account (today’s article notes you can invest in “almost anything” with an IRA), the critical question is what to select. For some insights on this question, taking into consideration how far you are from…
The Vanguard Dividend Appreciation ETF, which seeks to track companies that have consistently increased their dividends for ten consecutive years, may seem like a great pick for retirees looking for reliable income. As today’s article points out, however, there is a problem: despite holding companies that have a track record of raising their dividends for ten consecutive years, the ETF…
Exchange-traded funds may have exploded in popularity over the last few years, but that surge in popularity has varied greatly by generation. Today’s article notes that boomers have not embraced ETFs to the extent that millennials – or even the oldest generation of investors – have, with one study finding that only 27% of boomers aged 52 to 70 with…
Leverage and retirement don’t conventionally go together – but a new exchange-traded fund targeting retirees who require more income than they can get from a typical 60-40 stock-bond portfolio is looking to include a leverage component in an effort to provide investors with superior returns. As today’s article outlines, “this fund takes those vanilla investments, adds a dollop of exposure…
The author of today’s article calls it “one of the more underutilized strategies for taxable investment accounts”. That strategy? Tax-loss harvesting, whereby poor performers are sold at a loss in order to offset that year’s capital gains – and lessen one’s tax burden. The author proceeds to identify areas that may offer the best opportunities to exploit the tax-loss harvesting…